Difference between revisions of "Liposarcoma"

Jump to navigation Jump to search
118 bytes removed ,  03:15, 19 September 2014
(One intermediate revision by the same user not shown)
Line 35: Line 35:
*Most common malignant sarcoma in the retroperitoneum.
*Most common malignant sarcoma in the retroperitoneum.
*Not all (large) retroperitoneal adipocytic tumours are liposarcomas.
*Not all (large) retroperitoneal adipocytic tumours are liposarcomas.
*Prognosis - good-to-moderate dependent on stage.
*Prognosis - dependent on the location.
**Five year survival for retroperitoneal liposarcoma in one series (per AJCC 6th edition): stage I = 96%, stage II = 58% stage III = 42%.<ref name=pmid19101765>{{Cite journal  | last1 = Anaya | first1 = DA. | last2 = Lahat | first2 = G. | last3 = Wang | first3 = X. | last4 = Xiao | first4 = L. | last5 = Tuvin | first5 = D. | last6 = Pisters | first6 = PW. | last7 = Lev | first7 = DC. | last8 = Pollock | first8 = RE. | title = Establishing prognosis in retroperitoneal sarcoma: a new histology-based paradigm. | journal = Ann Surg Oncol | volume = 16 | issue = 3 | pages = 667-75 | month = Mar | year = 2009 | doi = 10.1245/s10434-008-0250-2 | PMID = 19101765 }}</ref>  
**Retroperitoneal: poor.
**Extremity: good - disease specific 5-year survival ~ 92%.<ref>{{Cite journal  | last1 = Lietman | first1 = SA. | last2 = Barsoum | first2 = WK. | last3 = Goldblum | first3 = JR. | last4 = Marks | first4 = KE. | last5 = Mascha | first5 = E. | last6 = Sundaram | first6 = M. | last7 = Muschler | first7 = G. | title = A 20-year retrospective review of surgically treated liposarcoma at the Cleveland Clinic. | journal = Orthopedics | volume = 30 | issue = 3 | pages = 227-34 | month = Mar | year = 2007 | doi = | PMID = 17375550 }}</ref>  


Notes:
Notes:
48,453

edits

Navigation menu